Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Med Pr ; 72(3): 327-334, 2021 Jun 30.
Article in Polish | MEDLINE | ID: covidwho-1413301

ABSTRACT

Generally, COVID-19 is an acute contagious disease caused by the SARS­CoV-2 virus. The main route of human-to-human transmission is through contact with infectious secretions from the respiratory tract. Clinical manifestations vary from mild non-specific symptoms to life-threatening conditions. Since WHO declared COVID-19 a pandemic in March 2020, it has affected many medical, legal, social and economic aspects of everyday life in countries around the world. In this article, the authors present a summary of recommendations for taking care of otorhinolaryngology patients in outpatient settings and the legal basis referring to a risk of infection in doctor's office. In the selection of articles, the authors used English- and Polish-language online medical databases, typing the following keywords: SARS­CoV-2, COVID-19, otolaryngology, endoscopy, personal protective equipment, and legal responsibility of the physician. The mucosa of the upper respiratory tract is a potential site of virus replication. The specificity of an ear, nose and throat (ENT) examination and a direct patient-doctor contact favor the transmission of the infection. The authors discussed the elements of self-protection of medical personnel and the legal aspects a risk of the patient contracting the infection in the otolaryngology office. In the case of a direct contact with the patient, the following medical personal protective equipment is required: a cap, a mask with an FFP-2 filter, goggles, an apron and gloves. If, during the visit, exposure to secretions or aerosol from the respiratory tract is expected, the personnel should additionally wear a visor and a waterproof apron. The patient's visit in the clinic should be preceded by telemedicine consultation. Patients should be screened prior to having a direct contact with a physician, using a short patient questionnaire. The questionnaire may consist of simple questions about the characteristic symptoms of the SARS­CoV-2 infection and exposure to a sick person in the past 14 days. The question of staying in the areas of a high infection risk appears of little importance in view of the whole of Poland being perceived as constituting such an area. Due to the spread of the SARS­CoV-2 virus, new procedures for providing medical services have been introduced. In the case of claims on the part of the patient, the only protection the medical personnel or facility can provide is confirmation of scrupulous compliance with medical procedures . Med Pr. 2021;72(3):327-34.


Subject(s)
COVID-19/prevention & control , Infection Control/standards , Otolaryngology/standards , COVID-19/transmission , Health Personnel , Humans , Infection Control/legislation & jurisprudence , Otolaryngology/legislation & jurisprudence , Personal Protective Equipment
2.
Sci Prog ; 104(3): 368504211036319, 2021.
Article in English | MEDLINE | ID: covidwho-1331871

ABSTRACT

The pandemic of "Corona Virus Disease 2019" (COVID-19) has changed the lives of people. There have been changes in common outpatient and emergency cases in otolaryngology, so an analysis of data pertaining to this was completed. This study is to evaluate the impact of viral infection disease in otolaryngological common disease. This study uses the data of common diseases in the outpatient and emergency department during the "COVID-19" pandemic (from February to April 2020) and the same period in the past 3 years from the Department of Otolaryngology. During the "COVID-19" period compared with the same period last year, the ranking of cases by diseases has changed. Diseases such as chronic pharyngitis, allergic rhinitis, sudden deafness, and tinnitus increased, meanwhile acute pharyngitis and acute laryngopharyngitis decreased (p < 0.05). The viral infection has impacted the mental behaviors of people, therefore mental-related disease cases of the department of Otolaryngology have increased indirectly. This study provides real data to illustrate mental-related diseases. It also provides experience and shows the importance of keeping and maintaining mental health.


Subject(s)
COVID-19 , Emergency Medical Services , Otorhinolaryngologic Diseases/therapy , Outpatients , SARS-CoV-2 , Humans , Otolaryngology/standards , Retrospective Studies , Time Factors
3.
Otolaryngol Clin North Am ; 54(1): 11-23, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-1235961

ABSTRACT

A new era of surgical visualization and magnification is poised to disrupt the field of otology and neurotology. The once revolutionary benefits of the binocular microscope now are shared with rigid endoscopes and exoscopes. These 2 modalities are complementary. The endoscope improves visualization of the hidden recesses through the external auditory canal or canal-up mastoidectomy. The exoscope provides an immersive visual experience and superior ergonomics compared with binocular microscopy. Endoscopes and exoscopes are poised to disrupt the standard of care for surgical visualization and magnification in otology and neurotology.


Subject(s)
COVID-19 , Endoscopes/standards , Endoscopy/instrumentation , Neurotology/instrumentation , Otolaryngology/instrumentation , Pandemics , Ear Canal/surgery , Endoscopy/standards , Equipment Design/standards , Humans , Mastoidectomy/instrumentation , Microsurgery/instrumentation , Minimally Invasive Surgical Procedures/instrumentation , Neurosurgical Procedures/instrumentation , Neurotology/standards , Otolaryngology/standards , Standard of Care/standards , United States
4.
J Laryngol Otol ; 135(7): 584-588, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1207119

ABSTRACT

BACKGROUND: The impact of coronavirus disease 2019 on healthcare has led to rapid changes in otolaryngology service provisions. As such, new standard operating procedures for the management of suspected tonsillitis or quinsy were implemented in our centre. METHODS: A retrospective audit was performed of acute referrals to ENT of patients with suspected tonsillitis, peritonsillar cellulitis or quinsy, during the 10 weeks before (group 1) and 10 weeks after (group 2) implementation of the new standard operating procedures. RESULTS: Group 2 received fewer referrals. Fewer nasendoscopies were performed and corticosteroid use was reduced. The frequency of quinsy drainage performed under local anaesthetic increased, although the difference was not statistically significant. Hospital admission rates decreased from 56.1 to 20.4 per cent, and mean length of stay increased from 1.13 to 1.5 days. Face-to-face follow up decreased from 15.0 to 8.2 per cent, whilst virtual follow up increased from 4.7 to 16.3 per cent. There were no significant differences in re-presentation or re-admission rates. CONCLUSION: Management of suspected tonsillitis or quinsy using the new standard operating procedures appears to be safe and effective. This management should now be applied to an out-patient setting in otherwise systemically well patients.


Subject(s)
COVID-19/epidemiology , Peritonsillar Abscess/therapy , Quality Improvement , Tonsillitis/therapy , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy, Fine-Needle , Drainage , Female , Hospitalization/statistics & numerical data , Humans , Length of Stay/statistics & numerical data , London , Male , Middle Aged , Otolaryngology/methods , Otolaryngology/standards , Otolaryngology/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data , Referral and Consultation , Retrospective Studies , Young Adult
5.
Ann Otol Rhinol Laryngol ; 130(11): 1245-1253, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1140414

ABSTRACT

OBJECTIVES: Define aerosol and droplet risks associated with routine otolaryngology clinic procedures during the COVID-19 era. METHODS: Clinical procedures were simulated in cadaveric heads whose oral and nasal cavities were coated with fluorescent tracer (vitamin B2) and breathing was manually simulated through retrograde intubation. A cascade impactor placed adjacent to the nares collected generated particles with aerodynamic diameters ≤14.1 µm. The 3D printed models and syringes were used to simulate middle and external ear suctioning as well as open suctioning, respectively. Provider's personal protective equipment (PPE) and procedural field contamination were also recorded for all trials using vitamin B2 fluorescent tracer. RESULTS: The positive controls of nebulized vitamin B2 produced aerosol particles ≤3.30 µm and endonasal drilling of a 3D model generated particles ≤14.1 µm. As compared with positive controls, aerosols and small droplets with aerodynamic diameter ≤14.1 µm were not detected during rigid nasal endoscopy, flexible fiberoptic laryngoscopy, and rigid nasal suction of cadavers with simulated breathing. There was minimal to no field contamination in all 3 scenarios. Middle and external ear suctioning and open container suctioning did not result in any detectable droplet contamination. The clinic suction unit contained all fluorescent material without surrounding environmental contamination. CONCLUSION: While patients' coughing and sneezing may create a baseline risk for providers, this study demonstrates that nasal endoscopy, flexible laryngoscopy, and suctioning inherently do not pose an additional risk in terms of aerosol and small droplet generation. An overarching generalization cannot be made about endoscopy or suctioning being an aerosol generating procedure. LEVEL OF EVIDENCE: 3.


Subject(s)
Aerosols/adverse effects , COVID-19 , Disease Transmission, Infectious/prevention & control , Endoscopy , Otolaryngology , Risk Adjustment/methods , Suction , COVID-19/prevention & control , COVID-19/transmission , Cadaver , Endoscopy/adverse effects , Endoscopy/instrumentation , Endoscopy/methods , Humans , Otolaryngology/methods , Otolaryngology/standards , Outcome Assessment, Health Care , Personal Protective Equipment/classification , Personal Protective Equipment/virology , Research Design , Risk Assessment/methods , SARS-CoV-2 , Suction/adverse effects , Suction/instrumentation , Suction/methods
6.
J Laryngol Otol ; 134(8): 670-679, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-1049931

ABSTRACT

BACKGROUND: Coronavirus disease 2019 has demanded enormous adjustments to National Health Service provisions. Non-urgent out-patient work was initially postponed or performed virtually, but is now being re-established. In ENT surgery, aerosol-generating procedures pose a particular challenge in out-patient settings. OBJECTIVE: A rapid restructuring of ENT out-patient services is required, to safely accommodate aerosol-generating procedures and increase in-person attendances, whilst coronavirus disease 2019 persists. METHODS: Data were collected prospectively over four consecutive cycles. Two surveys were conducted. Results were analysed and disseminated, with recommendations for service restructuring implemented at cycle end-points. RESULTS: Out-patient activity increased four-fold, associated with a significant rise in aerosol-generating procedures during the study period. Mean aerosol-generating procedure duration dropped weekly, implying a learning curve. Service restructuring occurred at cycle end-points. CONCLUSION: Iterative data gathering, results analysis and outcome dissemination enabled a swift, data-driven approach to the restructuring of ENT out-patient services. Patient and staff safety was ensured, whilst out-patient capacity was optimised.


Subject(s)
Coronavirus Infections/transmission , Otolaryngology/standards , Otorhinolaryngologic Surgical Procedures/statistics & numerical data , Outpatients/statistics & numerical data , Pneumonia, Viral/transmission , Aerosols , Betacoronavirus/isolation & purification , Body Fluids/virology , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , Hospital Restructuring/organization & administration , Humans , Incidence , National Health Programs/organization & administration , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/virology , Prospective Studies , Quality Improvement , SARS-CoV-2 , Surveys and Questionnaires , United Kingdom/epidemiology
8.
Clin Otolaryngol ; 46(2): 295-296, 2021 03.
Article in English | MEDLINE | ID: covidwho-1044488

ABSTRACT

During the COVID-19 pandemic, the ENT community has demonstrated strong clinical leadership, adaptability to rapid change, enhanced clinical pathways and local networks, widespread use of digital technology for consultation and teaching and redirection of research programmes. These have permanently changed the way we work and, when the current global pandemic improves as COVID-19 infections drop and vaccination programmes are rolled out, we should ensure that the positive changes that have been made are embedded in clinical practice to improve patient care.


Subject(s)
COVID-19/epidemiology , Otolaryngology/standards , Quality Improvement , Humans , Leadership , Pandemics , SARS-CoV-2
9.
J Otolaryngol Head Neck Surg ; 49(1): 81, 2020 Dec 03.
Article in English | MEDLINE | ID: covidwho-992570

ABSTRACT

Healthcare services in many countries have been partially or completely disrupted by the Coronavirus (COVID-19) pandemic since its onset in the end of 2019. Amongst the most impacted are the elective medical and surgical services in order to conserve resources to care for COVID-19 patients. As the number of infected patients decrease across Canada, elective surgeries are being restarted in a staged manner. Since Otolaryngologists - Head & Neck Surgeons manage surgical diseases of the upper aerodigestive tract where the highest viral load reside, it is imperative that these surgeries resume in a safe manner. The aim of this document is to compile the current best evidence available and provide expert consensus on the safe restart of rhinologic and skull base surgeries while discussing the pre-operative, intra-operative, and post-operative care and tips. Risk assessment, patient selection, case triage, and pre-operative COVID-19 testing will be analyzed and discussed. These guidelines will also consider the optimal use of personal protective equipment for specific cases, general and specific operative room precautions, and practical tips of intra-operative maneuvers to optimize patient and provider safety. Given that the literature surrounding COVID-19 is rapidly evolving, these recommendations will serve to start our specialty back into elective rhinologic surgeries over the next months and they may change as we learn more about this disease.


Subject(s)
COVID-19 Testing , COVID-19 , Nose/surgery , Otolaryngology/standards , Otorhinolaryngologic Surgical Procedures/standards , Pandemics , Personal Protective Equipment/standards , Preoperative Care/standards , Skull Base/surgery , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/prevention & control , Disease Transmission, Infectious/prevention & control , Humans , Otolaryngology/methods , Otorhinolaryngologic Diseases/surgery , Postoperative Care/standards , Preoperative Care/methods
10.
Laryngoscope ; 131(8): 1876-1883, 2021 08.
Article in English | MEDLINE | ID: covidwho-978151

ABSTRACT

OBJECTIVE/HYPOTHESIS: To review the literature on pediatric ENT COVID-19 guidelines worldwide, in particular, surgical practice during the pandemic, and to establish a comprehensive set of recommendations. STUDY DESIGN: Review. METHODS: A comprehensive literature review through an independent electronic search of the COVID-19 pandemic in PubMed, Medline, Google, and Google Scholar was performed on April 26-30, 2020. Resources identified comprised of published papers, national and international pediatric ENT society guidelines. RESULTS: Fourteen guidelines fit the inclusion criteria. Key statements were formulated and graded: 1) Strong recommendation (reported by 9 or more/14); 2) Fair recommendation (7-8/14); 3) Weak recommendation (5-6/14); and 4) Expert opinion (2-4/14). Any single source suggestion was included as a comment. Highly scored recommendations included definition of urgent/emergent cases that required surgery; surgery for acute airway obstruction; prompt diagnosis of suspected cancer; and surgical intervention for sepsis following initial first-line medical management. Other well scored recommendations included senior faculty to perform the surgery; the use of open approaches rather than endoscopic ones; and avoidance of powered instruments that would aerosolize virus-loaded tissue. A tracheostomy should be performed on a case by case basis where key technical modifications become necessary. CONCLUSIONS: The COVID-19 pandemic will have a profound short and long-term impact on pediatric ENT practice. During this rapidly evolving climate, guidelines have been based on local practice and expert opinion. Until evidence-based practice in the COVID era is established, a comprehensive set of recommendations for pediatric ENT surgical practice based on a review of currently available literature and guidelines, is therefore, appropriate. Laryngoscope, 131:1876-1883, 2021.


Subject(s)
COVID-19/prevention & control , Infection Control/standards , Otolaryngology/standards , Otorhinolaryngologic Surgical Procedures/standards , Pediatrics/standards , Practice Guidelines as Topic , Child , Humans , SARS-CoV-2
11.
Head Neck ; 43(2): 733-738, 2021 02.
Article in English | MEDLINE | ID: covidwho-932433

ABSTRACT

This article provides best practice guidelines regarding nasopharyngolaryngoscopy and OHNS clinic reopening during the COVID-19 pandemic. The aim is to provide evidence-based recommendations defining the risks of COVID-19 in clinic, the importance of pre-visit screening in addition to testing, along with ways to adhere to CDC guidelines for environmental, source, and engineering controls.


Subject(s)
COVID-19/prevention & control , Disease Transmission, Infectious/prevention & control , Otolaryngology/standards , COVID-19/diagnosis , COVID-19/transmission , COVID-19 Testing/standards , Endocrinology/standards , Humans , Mass Screening/standards , Nasal Surgical Procedures/standards , Personal Protective Equipment , Risk , SARS-CoV-2
12.
Otolaryngol Head Neck Surg ; 163(1): 121-131, 2020 07.
Article in English | MEDLINE | ID: covidwho-913955

ABSTRACT

Objective. To describe coronavirus disease 2019 (COVID-19) patient presentations requiring otolaryngology consultation and provide recommendations for protective measures based on the experience of ear, nose, and throat (ENT) departments in 4 Chinese hospitals during the COVID-19 pandemic. Study Design. Retrospective case series. Setting. Multicenter. Subjects and Methods. Twenty hospitalized COVID-19 patients requiring ENT consultation from 3 designated COVID-19 hospitals in Wuhan, Shanghai, and Shenzhen were identified. Data on demographics, comorbidities, COVID-19 symptoms and severity, consult reason, treatment, and personal protective equipment (PPE) use were collected and analyzed. Infection control strategies implemented for ENT outpatients and emergency room visits at the Eye and ENT Hospital of Fudan University were reported. Results. Median age was 63 years, 55% were male, and 95% were in severe or critical condition. Six tracheotomies were performed. Posttracheotomy outcomes were mixed (2 deaths, 2 patients comatose, all living patients still hospitalized). Other consults included epistaxis, pharyngitis, nasal congestion, hyposmia, rhinitis, otitis externa, dizziness, and tinnitus. At all hospitals, powered air-supply filter respirators (PAPRs) were used for tracheotomy or bleeding control. PAPR or N95-equivalent masks plus full protective clothing were used for other complaints. No inpatient ENT providers were infected. After implementation of infection control strategies for outpatient clinics, emergency visits, and surgeries, no providers were infected at the Eye and ENT Hospital of Fudan University. Conclusions and Relevance. COVID-19 patients require ENT consultation for many reasons, including tracheotomy. Otolaryngologists play an indispensable role in the treatment of COVID-19 patients but, due to their work, are at high risk of exposure. Appropriate protective strategies can prevent infection of otolaryngologists.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Disease Transmission, Infectious/prevention & control , Otolaryngology/standards , Otorhinolaryngologic Diseases/therapy , Pandemics , Personal Protective Equipment/standards , Pneumonia, Viral/epidemiology , Adult , Aged , COVID-19 , China/epidemiology , Coronavirus Infections/complications , Coronavirus Infections/transmission , Female , Humans , Male , Middle Aged , Otorhinolaryngologic Diseases/complications , Pneumonia, Viral/complications , Pneumonia, Viral/transmission , Retrospective Studies , SARS-CoV-2
13.
Otolaryngol Head Neck Surg ; 163(1): 132-134, 2020 07.
Article in English | MEDLINE | ID: covidwho-913951

ABSTRACT

There is accumulating anecdotal evidence that anosmia and dysgeusia are associated with the COVID-19 pandemic. To investigate their relationship to SARS-CoV2 infection, the American Academy of Otolaryngology-Head and Neck Surgery developed the COVID-19 Anosmia Reporting Tool for Clinicians for the basis of this pilot study. This tool allows health care providers to confidentially submit cases of anosmia and dysgeusia related to COVID-19. We analyzed the first 237 entries, which revealed that anosmia was noted in 73% of patients prior to COVID-19 diagnosis and was the initial symptom in 26.6%. Some improvement was noted in 27% of patients, with a mean time to improvement of 7.2 days in this group (85% of this group improved within 10 days). Our findings suggest that anomia can be a presenting symptom of COVID-19, consistent with other emerging international reports. Anosmia may be critical in timely identification of individuals infected with SARS-CoV2 who may be unwittingly transmitting the virus.


Subject(s)
Betacoronavirus , Coronavirus Infections/complications , Olfaction Disorders/epidemiology , Otolaryngology/standards , Pandemics , Pneumonia, Viral/complications , COVID-19 , Coronavirus Infections/epidemiology , Global Health , Humans , Incidence , Olfaction Disorders/etiology , Pneumonia, Viral/epidemiology , SARS-CoV-2 , Smell
14.
Laryngoscope ; 131(3): E746-E754, 2021 03.
Article in English | MEDLINE | ID: covidwho-893245

ABSTRACT

OBJECTIVES/HYPOTHESIS: To compare personal protective equipment (PPE) guidelines, specifically respirator use, among international public health agencies, academic hospitals, and otolaryngology-head and neck surgery (OHNS) departments in the United States for the care of coronavirus-19 (COVID-19) patients. STUDY DESIGN: Cross sectional survey. METHODS: Review of publicly available public health and academic hospitals guidelines along with review of communication among otolaryngology departments. RESULTS: Among 114 academic institutions affiliated with OHNS residencies, 20 (17.5%) institutions provided public access to some form of guidance on PPE and 73 (64%) provided information on screening or diagnostic testing. PPE guidelines were uniquely described based on several variables: location of care, COVID-19 status, involvement of aerosol generating or high-risk procedures, and physical distance from the patient. Six hospital guidelines were highlighted. Across these six institutions, there was agreement that N95 respirators were needed for high-risk patients undergoing high-risk procedures. Variations existed among institutions for scenarios with low-risk patients. Definitions of the low-risk patient and high-risk procedures were inconsistent among institutions. Three of the highlighted institutions had OHNS departments recommending higher level of airway protection than the institution. CONCLUSIONS: OHNS departments typically had more stringent PPE guidance than their institution. Discrepancies in communicating PPE use were frequent and provide inconsistent information on how healthcare workers should protect themselves in the COVID-19 pandemic. Identification of these inconsistencies serves as an opportunity to standardize communication and develop evidence-based guidelines. LEVEL OF EVIDENCE: V Laryngoscope, 131:E746-E754, 2021.


Subject(s)
COVID-19/transmission , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Otolaryngology/standards , Personal Protective Equipment/standards , Practice Guidelines as Topic , Academic Medical Centers/standards , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/therapy , COVID-19 Testing/standards , Evidence-Based Medicine/standards , Health Personnel/standards , Humans , Pandemics/prevention & control , SARS-CoV-2/pathogenicity , Surgery Department, Hospital/standards , United States/epidemiology
15.
Eur Arch Otorhinolaryngol ; 277(12): 3529-3532, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-757968

ABSTRACT

BACKGROUND: Mastoidectomy is associated with extensive bone-drilling which makes it a major aerosol generating procedure. Considering the ongoing COVID-19 global pandemic, it is essential to devise methods to minimize aerosolization and hence ensure safety of the healthcare workers during the operative procedure. METHODS: Two disposable surgical drapes are used to create a closed pocket prior to commencement of mastoid bone-drilling. This limits aerosolization of bone-dust in the external operating theatre environment. CONCLUSION: Two-drape closed pocket technique is an easy, cost-effective and safe method to limit aerosolization of tissue particles during mastoidectomy.


Subject(s)
Coronavirus Infections/transmission , Infection Control/methods , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Operating Rooms/standards , Otolaryngology/standards , Pandemics/legislation & jurisprudence , Pneumonia, Viral/transmission , Aerosols/adverse effects , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Dust , Humans , Mastoid/surgery , Mastoidectomy , Otolaryngology/instrumentation , Pandemics/prevention & control , Personal Protective Equipment/virology , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , SARS-CoV-2 , Surgical Equipment
16.
J Laryngol Otol ; 134(8): 717-720, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-729969

ABSTRACT

OBJECTIVE: To evaluate the prevalence of severe acute respiratory syndrome coronavirus-2 infection in patients presenting with epistaxis to a tertiary otolaryngology unit. METHODS: A prospective study was conducted of 40 consecutive patients presenting with epistaxis referred to our tertiary otolaryngology unit. A group of 40 age-matched controls were also included. All patients underwent real-time reverse transcriptase polymerase chain reaction testing for severe acute respiratory syndrome coronavirus-2. Symptoms of fever, cough and anosmia were noted in the study group. RESULTS: The mean age was 66.5 ± 22.4 years in the study group. There were 22 males (55 per cent) and 18 females (45 per cent). The mean age in the control group was 66.3 ± 22.4 years (p = 0.935). There were six positive cases for severe acute respiratory syndrome coronavirus-2 (15 per cent) in the epistaxis group and one case (2.5 per cent) in the control group. The difference was statistically significant (p = 0.05). CONCLUSION: Epistaxis may represent a presenting symptom of severe acute respiratory syndrome coronavirus-2 infection. This may serve as a useful additional criterion for screening patients.


Subject(s)
Betacoronavirus/genetics , Coronavirus Infections/complications , Coronavirus Infections/epidemiology , Epistaxis/diagnosis , Pneumonia, Viral/complications , Pneumonia, Viral/epidemiology , Adult , Aged , Aged, 80 and over , Betacoronavirus/isolation & purification , COVID-19 , Case-Control Studies , Coronavirus Infections/drug therapy , Coronavirus Infections/virology , Cough/diagnosis , Cough/virology , Epistaxis/epidemiology , Epistaxis/virology , Female , Fever/diagnosis , Fever/virology , Humans , Male , Middle Aged , Olfaction Disorders/diagnosis , Olfaction Disorders/virology , Otolaryngology/standards , Pandemics , Pneumonia, Viral/drug therapy , Pneumonia, Viral/virology , Prevalence , Prospective Studies , Real-Time Polymerase Chain Reaction , SARS-CoV-2 , Tertiary Care Centers/standards , United Kingdom/epidemiology
17.
J Laryngol Otol ; 134(8): 710-716, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-728953

ABSTRACT

OBJECTIVE: A study was carried out to evaluate the relationship between anosmia and hospital admission in coronavirus disease 2019 patients. METHODS: The clinical data of 1534 patients with confirmed coronavirus disease 2019 virus were analysed. The study was conducted with medical records of 1197 patients (78 per cent). The basic characteristics of patients and symptoms related to otolaryngology practice were examined. The patients were divided into two groups according to their follow up: an out-patient group and an in-patient group. RESULTS: The majority of patients presented with anosmia (44.2 per cent), dysgeusia (43.9 per cent) and fever (38.7 per cent). Anosmia was observed in 462 patients (47 per cent) in the out-patient group, and in only 67 patients (31.2 per cent) in the in-patient group. Younger age (odds ratio = 1.05, 95 per cent confidence interval = 1.03-1.06) and the presence of anosmia (odds ratio = 2.04, 95 per cent confidence interval = 1.39-3) were significantly related to out-patient treatment. CONCLUSION: Anosmia could be a symptom in the clinical presentation of the coronavirus disease 2019 infection.


Subject(s)
Coronavirus Infections/complications , Hospitalization/statistics & numerical data , Olfaction Disorders/diagnosis , Otolaryngology/standards , Pneumonia, Viral/complications , Adult , Betacoronavirus/genetics , Betacoronavirus/isolation & purification , COVID-19 , Case-Control Studies , Comorbidity , Coronavirus Infections/drug therapy , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , Dysgeusia/diagnosis , Dysgeusia/epidemiology , Female , Fever/diagnosis , Fever/epidemiology , Hospitalization/trends , Humans , Inpatients/statistics & numerical data , Male , Middle Aged , Olfaction Disorders/etiology , Olfaction Disorders/virology , Outpatients/statistics & numerical data , Pandemics , Pneumonia, Viral/drug therapy , Pneumonia, Viral/epidemiology , Pneumonia, Viral/virology , SARS-CoV-2 , Turkey/epidemiology
18.
J Laryngol Otol ; 134(8): 661-664, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-604804

ABSTRACT

BACKGROUND: The following position statement from the Union of the European Phoniatricians, updated on 25th May 2020 (superseding the previous statement issued on 21st April 2020), contains a series of recommendations for phoniatricians and ENT surgeons who provide and/or run voice, swallowing, speech and language, or paediatric audiology services. OBJECTIVES: This material specifically aims to inform clinical practices in countries where clinics and operating theatres are reopening for elective work. It endeavours to present a current European view in relation to common procedures, many of which fall under the aegis of aerosol generating procedures. CONCLUSION: As evidence continues to build, some of the recommended practices will undoubtedly evolve, but it is hoped that the updated position statement will offer clinicians precepts on safe clinical practice.


Subject(s)
Audiology/methods , Betacoronavirus/isolation & purification , Coronavirus Infections/prevention & control , Otolaryngology/methods , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Audiology/standards , COVID-19 , Child , Child, Preschool , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , Deglutition Disorders/diagnosis , Deglutition Disorders/surgery , Deglutition Disorders/virology , Europe/epidemiology , Humans , Mandatory Testing/standards , Otolaryngology/standards , Pediatrics/standards , Personal Protective Equipment/standards , Personal Protective Equipment/supply & distribution , Pneumonia, Viral/epidemiology , Pneumonia, Viral/virology , Practice Guidelines as Topic , SARS-CoV-2 , Societies, Medical/organization & administration , Voice Disorders/diagnosis , Voice Disorders/surgery , Voice Disorders/virology
19.
J Otolaryngol Head Neck Surg ; 49(1): 36, 2020 Jun 03.
Article in English | MEDLINE | ID: covidwho-505665

ABSTRACT

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for Coronavirus disease 2019 (COVID-19) has a predilection for infecting the mucosa of the upper and lower airways. Otolaryngologists and supporting health care workers (HCWs) are particularly at high risk of becoming infected while treating patients as many in-office procedures and surgeries are Aerosol Generating Medical Procedures (AGMP). Based on a review of the literature and various guidelines, recommendations are made to mitigate the risk to health care workers of becoming infected with SARS-CoV-2 while providing clinical care. RECOMMENDATIONS: During the COVID-19 pandemic all elective and non-time sensitive Otolaryngology procedures should be deferred to mitigate the risk of transmission of infection to HCWs. For non-AGMPs in all patients, even COVID-19 positive patients Level 1 PPE (surgical mask, gown, gloves and face shield or goggles) is sufficient. If local prevalence is favourable and patients are asymptomatic and test negative for SARS-CoV-2, Level 1 PPE can be used during short duration AGMPs, with limited risk of infected aerosol spread. For AGMPs in patients who test positive for SARS-CoV-2 a minimum of Level 2 PPE, with adequate protection of mucosal surfaces, is recommended (N95/FFP2 respirator, gown, double gloves, goggles or face shield and head cover). For long duration AGMPs that are deemed high-risk in COVID-19 positive patients, Level 3 PPE can provide a higher level of protection and be more comfortable during long duration surgeries if surgical hoods or PAPRs are used. It is recommended that these procedures are performed in negative pressure rooms, if available. It is essential to follow strict donning and doffing protocols to minimize the risk of contamination. CONCLUSIONS: By following strict infection prevention recommendations, the risk of HCWs becoming infected with SARS-CoV-2 while treating patients can be minimized. As the COVID-19 pandemic evolves rapidly, these recommendations should serve as guidance and need to be interpreted based on local factors and availability of healthcare resources.


Subject(s)
Coronavirus Infections/transmission , Infection Control/standards , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Otolaryngology/standards , Otorhinolaryngologic Diseases/therapy , Otorhinolaryngologic Surgical Procedures/standards , Pneumonia, Viral/transmission , Aerosols/adverse effects , Betacoronavirus , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/prevention & control , Health Personnel/standards , Humans , Otolaryngology/organization & administration , Otorhinolaryngologic Diseases/diagnosis , Pandemics/prevention & control , Pneumonia, Viral/diagnosis , Pneumonia, Viral/prevention & control , Practice Guidelines as Topic , Protective Devices/standards , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL